Shandong Wohua Pharmaceutical Co Ltd (002107) - Net Assets

Latest as of December 2025: CN¥720.90 Million CNY ≈ $105.49 Million USD

Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) has net assets worth CN¥720.90 Million CNY (≈ $105.49 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥977.37 Million ≈ $143.02 Million USD) and total liabilities (CN¥256.47 Million ≈ $37.53 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read Shandong Wohua Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥720.90 Million
% of Total Assets	73.76%
Annual Growth Rate	12.72%
5-Year Change	-22.42%
10-Year Change	25.89%
Growth Volatility	35.73

Shandong Wohua Pharmaceutical Co Ltd - Net Assets Trend (2003–2025)

This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 002107 asset base for the complete picture of this company's asset base.

Annual Net Assets for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)

The table below shows the annual net assets of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025. For live valuation and market cap data, see 002107 company net worth.

Year	Net Assets	Change
2025-12-31	CN¥720.90 Million ≈ $105.49 Million	-0.28%
2024-12-31	CN¥722.93 Million ≈ $105.79 Million	-13.26%
2023-12-31	CN¥833.48 Million ≈ $121.96 Million	+5.53%
2022-12-31	CN¥789.79 Million ≈ $115.57 Million	-15.01%
2021-12-31	CN¥929.26 Million ≈ $135.98 Million	+1.23%
2020-12-31	CN¥918.01 Million ≈ $134.33 Million	+18.43%
2019-12-31	CN¥775.15 Million ≈ $113.43 Million	+11.41%
2018-12-31	CN¥695.78 Million ≈ $101.81 Million	+6.10%
2017-12-31	CN¥655.78 Million ≈ $95.96 Million	+14.52%
2016-12-31	CN¥572.64 Million ≈ $83.79 Million	+4.64%
2015-12-31	CN¥547.26 Million ≈ $80.08 Million	-13.37%
2014-12-31	CN¥631.74 Million ≈ $92.44 Million	+4.41%
2013-12-31	CN¥605.04 Million ≈ $88.54 Million	+1.79%
2012-12-31	CN¥594.41 Million ≈ $86.98 Million	+1.42%
2011-12-31	CN¥586.07 Million ≈ $85.76 Million	-0.77%
2010-12-31	CN¥590.64 Million ≈ $86.43 Million	-14.21%
2009-12-31	CN¥688.45 Million ≈ $100.74 Million	+7.93%
2008-12-31	CN¥637.88 Million ≈ $93.34 Million	+86.40%
2007-12-31	CN¥342.22 Million ≈ $50.08 Million	+140.04%
2006-12-31	CN¥142.57 Million ≈ $20.86 Million	+28.37%
2005-12-31	CN¥111.06 Million ≈ $16.25 Million	+34.42%
2004-12-31	CN¥82.62 Million ≈ $12.09 Million	+59.85%
2003-12-31	CN¥51.69 Million ≈ $7.56 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Shandong Wohua Pharmaceutical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 751.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥84.66 Million	11.70%
Other Components	CN¥639.16 Million	88.30%
Total Equity	CN¥723.82 Million	100.00%

Shandong Wohua Pharmaceutical Co Ltd Competitors by Market Cap

The table below lists competitors of Shandong Wohua Pharmaceutical Co Ltd ranked by their market capitalization.

Company	Market Cap
Zhejiang Yueling Co Ltd SHE:002725	$563.41 Million
Lanzhou Foci Pharmaceutical Co Ltd SHE:002644	$563.43 Million
Anhui Quanchai Engine Co Ltd SHG:600218	$563.48 Million
Shanghai New Huang Pu Real Estate Co Ltd SHG:600638	$563.64 Million
Shenzhen Asiantime International Construction Co Ltd SHE:002811	$563.32 Million
UE Furniture Co Ltd SHG:603600	$563.31 Million
NatWest Group PLC LSE:NWG	$563.19 Million
Pareto Bank ASA OL:PARB	$563.16 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Shandong Wohua Pharmaceutical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 697,368,305 to 723,818,446, a change of 26,450,141 (3.8%).
Net income of 95,715,293 contributed positively to equity growth.
Dividend payments of 69,265,152 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥95.72 Million	+13.22%
Dividends Paid	CN¥69.27 Million	-9.57%
Other Changes	CN¥0.40	+0.0%
Total Change	CN¥-	3.79%

Book Value vs Market Value Analysis

This analysis compares Shandong Wohua Pharmaceutical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 5.32x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 46.91x to 5.32x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2003-12-31	CN¥0.14	CN¥6.67	x
2004-12-31	CN¥0.23	CN¥6.67	x
2005-12-31	CN¥0.31	CN¥6.67	x
2006-12-31	CN¥0.39	CN¥6.67	x
2007-12-31	CN¥0.70	CN¥6.67	x
2008-12-31	CN¥1.22	CN¥6.67	x
2009-12-31	CN¥1.20	CN¥6.67	x
2010-12-31	CN¥1.03	CN¥6.67	x
2011-12-31	CN¥1.12	CN¥6.67	x
2012-12-31	CN¥1.01	CN¥6.67	x
2013-12-31	CN¥0.97	CN¥6.67	x
2014-12-31	CN¥1.09	CN¥6.67	x
2015-12-31	CN¥0.83	CN¥6.67	x
2016-12-31	CN¥0.88	CN¥6.67	x
2017-12-31	CN¥0.96	CN¥6.67	x
2018-12-31	CN¥1.06	CN¥6.67	x
2019-12-31	CN¥1.16	CN¥6.67	x
2020-12-31	CN¥1.40	CN¥6.67	x
2021-12-31	CN¥1.42	CN¥6.67	x
2022-12-31	CN¥1.29	CN¥6.67	x
2023-12-31	CN¥1.37	CN¥6.67	x
2024-12-31	CN¥1.15	CN¥6.67	x
2025-12-31	CN¥1.25	CN¥6.67	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Shandong Wohua Pharmaceutical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 13.22%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 11.72%
• Asset Turnover: 0.84x
• Equity Multiplier: 1.35x
Recent ROE (13.22%) is above the historical average (11.28%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2003	24.16%	16.71%	0.55x	2.61x	CN¥7.32 Million
2004	28.00%	25.30%	0.60x	1.85x	CN¥14.87 Million
2005	25.61%	25.54%	0.57x	1.76x	CN¥17.33 Million
2006	22.10%	25.68%	0.52x	1.66x	CN¥17.25 Million
2007	10.35%	27.36%	0.29x	1.32x	CN¥1.20 Million
2008	8.41%	27.29%	0.28x	1.12x	CN¥-10.15 Million
2009	7.61%	30.41%	0.22x	1.12x	CN¥-16.47 Million
2010	-16.56%	-107.58%	0.14x	1.08x	CN¥-156.88 Million
2011	1.27%	4.99%	0.24x	1.06x	CN¥-51.17 Million
2012	1.40%	3.98%	0.33x	1.08x	CN¥-51.10 Million
2013	1.76%	4.16%	0.40x	1.07x	CN¥-49.88 Million
2014	5.79%	11.59%	0.47x	1.06x	CN¥-26.63 Million
2015	14.98%	15.22%	0.70x	1.40x	CN¥23.74 Million
2016	9.98%	8.67%	0.80x	1.44x	CN¥-92.18K
2017	10.40%	7.85%	0.85x	1.56x	CN¥2.19 Million
2018	7.68%	5.89%	0.84x	1.55x	CN¥-13.75 Million
2019	14.26%	11.14%	0.85x	1.50x	CN¥28.60 Million
2020	22.16%	17.78%	0.73x	1.70x	CN¥98.14 Million
2021	19.91%	17.33%	0.81x	1.41x	CN¥81.32 Million
2022	14.39%	10.58%	0.92x	1.47x	CN¥32.74 Million
2023	7.30%	6.46%	0.79x	1.42x	CN¥-21.76 Million
2024	5.22%	4.77%	0.77x	1.41x	CN¥-33.33 Million
2025	13.22%	11.72%	0.84x	1.35x	CN¥23.33 Million

Industry Comparison

This section compares Shandong Wohua Pharmaceutical Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,930,657,086
Average return on equity (ROE) among peers: -19.69%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Shandong Wohua Pharmaceutical Co Ltd (002107)	CN¥720.90 Million	24.16%	0.36x	$563.37 Million
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$1.06 Billion	5.59%	4.55x	$662.23 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$753.81 Million	5.52%	0.69x	$403.91 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$1.26 Billion	16.30%	0.27x	$4.68 Billion
Livzon Pharmaceutical Group Inc (000513)	$2.23 Billion	21.64%	0.40x	$2.67 Billion
Wedge Industrial Co Ltd (000534)	$596.67 Million	0.77%	0.03x	$2.67 Billion
Yunnan Baiyao Group Co Ltd (000538)	$39.91 Billion	10.26%	0.35x	$13.09 Billion
Hainan Haiyao Co Ltd (000566)	$590.38 Million	-258.34%	9.36x	$810.64 Million
Tus Pharmaceutical Group Co Ltd (000590)	$271.26 Million	1.07%	1.01x	$357.08 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$2.40 Billion	-16.01%	2.62x	$1.01 Billion
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$243.07 Million	16.30%	0.73x	$3.07 Billion

About Shandong Wohua Pharmaceutical Co Ltd

SHE:002107 China Drug Manufacturers - Specialty & Generic

Market Cap

$563.37 Million

CN¥3.85 Billion CNY

Market Cap Rank

#11956 Global

#3601 in China

Share Price

CN¥6.67

Change (1 day)

-3.75%

52-Week Range

CN¥5.47 - CN¥8.11

All Time High

CN¥17.57